A Review on Evaluation of Tablets

& f nal o Formu ur ion Science lat v Bioa ailabil i Journal of Haritha, J Formul Sci Bioavailab 2017, 1:1 Formulat

Views 99 Downloads 4 File size 1MB

Report DMCA / Copyright

DOWNLOAD FILE

Recommend stories

Citation preview

&

f nal o Formu ur

ion Science lat

v Bioa ailabil i

Journal of

Haritha, J Formul Sci Bioavailab 2017, 1:1

Formulation Science & Bioavailability

ty

Jo

Review Article

Open Access

A Review on Evaluation of Tablets Haritha B* ASN Pharmacy College, Tenali, Andhra Pradesh, India

Abstract Tablets are defined as solid unit dosage form of medicaments intended for oral use. They became most popular as they were easy in preparation compared to any other type of dosage forms. But the major drawback exists in its manufacturing. If any minor problem occurs during their manufacturing then the whole batch of the unit should be discarded. It is necessary to avoid any sort of errors during its manufacturing and as a result evaluation of tablets is very important before dispatching of a batch. In the present study, we discussed about the evaluation tests for tablets.

Keywords: Solid unit dosage; Compression method; Indian pharmacopoeia; Organoleptic properties

Introduction Tablets are a solid dosage form of medicaments with or without excipients which are prepared by compression method. According to the Indian Pharmacopoeia tablets are solid, flat or biconvex unit dosage form of a medicament alone or medicament along with excipients prepared by compressing technique. They may vary in its size shape and weight depending on the medicament and its mode of administration. Tablets are said to be most widely used conventional dosage forms due to its variety of advantages and 70% of the medicaments were dispensed in tablet forms. Most of the medicaments can be processed into tablets but there are some exceptions like medicaments with low density characters, hygroscopic and the medicaments which were not possible to administer. Post-compression studies (Evaluation parameters) plays a major role to release any dosage form into the market [1-25].

Advantages •

Unit dosage forms with dose precision,



Least content variability,



Administration of accurate amounts of minute doses of a drug is possible,



Economical of all oral dosage forms as its production doesn’t requires additional processing steps,



Easy transportation,



Sustain release of a drug can be achieved through enteric coating,



Medicaments with bitter taste can be masked with coating technique (Sugar coating),



Tablet dosage form is stable when compared to all oral dosage forms.

Evaluation of Tablets •

Appearance,



Size and Shape,



Organoleptic properties,



Uniformity of thickness,



Hardness,



Friability,



Drug Content Uniformity,



Weight Variation Test,



Wetting time,



Water Absorption Ratio,



In vitro Dispersion Time,



In vitro Disintegration Test,



In vitro Dissolution Studies,



Two set of apparatus,



Apparatus-1,



Apparatus-2.

Appearance Appearance is the first most required quality for the acceptance of tablet. General elegance and its identity play a major role for the consumer acceptance. Acceptance of the appearance of batches of the tablet has been done based on the measurement of the following factors like size, color, shape, presence or absence of odor, taste etc. [26-50].

Size and shape Size and shape of a tablet has been determined by its thickness.

Disadvantages Administration of drugs is not easy in case of children, Drugs with slow dissolution is not acceptable for tableting with good bioavailability, Medicaments with low density characters and amorphous in nature are difficult to compress, Hygroscopic nature of drugs is not acceptable for tablet compression. J Formul Sci Bioavailab, an open access journal

*Corresonding author: Haritha B, Professor, ASN Pharmacy College, Tenali, Andhra Pradesh, 522201, India; Tel: 086442 39595; E-mail: [email protected] Received March 20, 2017; Accepted April 04, 2017; Published April 08, 2017 Citation: Haritha B (2017) A Review on Evaluation of Tablets. J Formul Sci Bioavailab 1: 107. Copyright: © 2017 Haritha B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Volume 1 • Issue 1 • 1000107

Citation: Haritha B (2017) A Review on Evaluation of Tablets. J Formul Sci Bioavailab 1: 107.

Page 2 of 5 Size and shape of a tables plays an important role in its patient compliance as the size of the tablet increases it is not much easier for its administration. Micrometer is the devise which is used to determine the thickness of a tablet. It can be acceptable if the batch falls within the ±5% of standard deviation.

Organoleptic properties Color should be distributed uniformly without appearance of any signs of mottling. Colour of the tablet should be compared with the standard colour for comparison.

Uniformity of thickness To determine the uniformity of thickness random selection of tablets has to be done from each and every batch and need to measure its thickness independently. If the thickness of any single tablet varies then the batch containing that batch will not be dispatched into market (Figure 1).

Hardness The ability of a tablet to withstand for mechanical shocks is known as hardness. Pfizer hardness tester is the instrument which is used to determine the hardness of tablet. It is expressed in kg/cm2. Take three tablets from each batch and hardness should be determined and the selection of tabled should be done randomly. Then the mean and standard devialtion values should be determined.

Figure 2: Roche friabilator.

Average weight of the tablet

Percentage deviation

130 mg or less

10

More than 130 mg and less than 324 mg

7.5

Table 1: Percentage deviation in weight variation.

(μg/ml) was calculated by using the standard calibration curve of the respective drug [51-75].

Friability

Drug content is calculated by using the below formula

Roche friabilator is the equipment which is used for the determination of friability.

Concentration of the drug in (μg/ml) × 100 × 50/10 × 1000

It is expressed in percentage. Note down the initial weight of the tablets individually (W initial). Tablets are placed in a plastic chamber which revolves at 25 rpm and they are subjected to fall from a height of 6 inches in the friabilator for about 100 revolutions. Then measure the weight of the tablet (W final) and observe any weight difference before tablet and after the friabilator processing (Figure 2). Limits: loss in weight less than 0.5 to 1% of the initial weight of the tablet should be considered as acceptable limits. Percentage of friability is calculated as: F={(W initial)- (W final)/ (W initial)}×100.

Weight variation test Random selection of 20 tablets from each batch should be done and note down the weight of the tablet individually and check for any variation in its weight. According to US Pharmacopies small variations in the weight is negligible and can be accepted. Below is the acceptable limit of percentage deviation in weight variation (Table 1).

Wetting time This method was performed to determine the wetting time of a tablet. A piece of tissue paper which is folded twice is kept in a petridish containing 6 ml of water and place the tablet on the tissue paper. Observe the time taken for complete wetting of the tablet. Following procedure should follow three times (three trial) for each batch and standard deviation is also calculated from the obtained results.

Drug content uniformity

Water absorption ratio

Initially weigh the tablet and then powder it. Now the powdered tablet is transferred into a 100 ml volumetric flask and add 0.1 N HCl upto mark. Now filter the solution and discard first few ml of filtrate. Take 10 ml of filtrate should be taken into a 50 ml volumetric flask and add 0.1 N HCl up to the mark and analysed spectrophotometrically at 274 nm and 234.5 nm. The concentration of the content of the drug

A piece of tissue paper which is folded twice is kept in a petridish (i.d.=6.5 cm) containing 6 ml of water and place the tablet on the tissue paper. Observe the time taken for complete wetting of the tablet. Thus wetted tablet was weighed. Now the water absorption ratio R is calculated using the formula R=100 × Wa –Wb/Wb Wb is the weight of the tablet before absorption, Wa is the weight of the tablet after absorption, Following procedure should follow three times (three trial) for each batch and standard deviation is also calculated from the obtained results.

In vitro dispersion time Figure 1: Vernier callipers used to determine the diameter of the tablet.

J Formul Sci Bioavailab, an open access journal

Dispersion time of a tablet is determined by placing a tablet in 6 ml Volume 1 • Issue 1 • 1000107

Citation: Haritha B (2017) A Review on Evaluation of Tablets. J Formul Sci Bioavailab 1: 107.

Page 3 of 5 8. Vargas M, Villarraga EA (2016) Bioequivalence Study of Two Formulations Containing Lurasidone 80 mg Tablets in Healthy Colombian Volunteers. J Bioequiv Availab. 9. Shabana. Md (2016) A Review on the Quality Control Analysis of Oral Dosage Form: Tablets. Journal of Pharmacy and Pharmaceutical Sciences. 10. Newton AMJ, Bindu B, Archana C (2016) Comparative Study on Starch Citrate Vs Other Super Disintegrants in the Formulation Characteristics and In vitro Profile of Ondansetron Sublingual Tablets by Direct Compression. Journal of Pharmacy and Pharmaceutical Sciences. 11. El Abass SA, Walash MI, Ibrahim F (2016) Development and Validation of Spectrophotometric and Pre-column Derivatization HPLC Method for Determination of Famotidine in Pharmaceuticals by Reaction with Sodium Nitroprusside; Application to Combined Tablets. Pharm Anal Acta 7: 476. 12. Aksil TA, Abbas M, Trari M, Benamara S (2016) Matrix Tablets from Algerian Lyophilized Berries (LB) (Arbutus unedo L.) Date (Phoenix dactylifera L.). Nat Prod Chem Res 4: 207. Figure 3: In vitro disintegration test.

of 6.8 pH phosphate buffer and note down the time taken for complete dispersion of tablet. Following procedure should be done for three tablets from each batch and in vitro dispersion time is calculated. Standard deviation time is also determined from the obtained results. It is expressed in seconds [76-102].

In vitro disintegration test Disintegration is defined as the process of breakdown of tablet into small particles. Disintegration time of a tablet is determined by using disintegration test apparatus as per IP specifications. Place each tablet in each 6 tubes of the disintegration apparatus a then add a disc to each tube containing 6.8 pH phosphate buffer. The temperature of the buffer should maintain at 37 ± 2°C and run the apparatus raised and lowered for 30 cycles per minute. Note down the time taken for the complete disintegration of the tablet without any remitants (Figure 3). Two set of apparatus

Conclusion Tablets are the conventional dosage forms compared to any other oral dosage forms. It is necessary for pharmaceutical manufacturers to develop a given drug entity in a new and improved dosage form with a good bioavailability. Every batch of the tablets should undergo the above-mentioned evaluation tests before dispatching in to markets.

13. Smith C, Piamjariyakul U, Werkowitch M, Yadrich DM, Thompson N, et al (2016) A Clinical Trial of Translation of Evidence Based Interventions to Mobile Tablets and Illness Specific Internet Sites. Int J Sens Netw Data Commun. 14. Yoshizumi Y, Mikushi S, Nakane A, Tohara H, Minakuchi S, et al. (2016) Dynamics of Swallowing Tablets during the Recovery Period following Surgery for Tongue Cancer. Otolaryngol (Sunnyvale) 5: 218. 15. Srivastava R, Chaturvedi D (2015) Formulation, Characterization and Evaluation of Gastro-Retentive Floating Tablets of Norfloxacin. Research & Reviews in Pharmacy and Pharmaceutical Sciences. 16. Kubo Y, Nogita T, Kimura I, Chiba M, Sakakibara K, et al. (2016) Interventional Evaluation of Monoammonium Glycyrrhizinate-Glycine/DLMethionine Combination Tablets in Mild Alopecia Areata. J Clin Exp Dermatol Res 7: 322. 17. Gul S, Sajid S (2016) Formulation of Improved Norfloxacin HCl Tablets: Quality Control Assessment and Comparison Study of Acidic and Basic Form of Norfloxacin in Tablet Formulation. J Dev Drugs 5: 145. 18. Malvey S, Kshirasagar N, Vishnu YV, Srikanth J (2015) Formulation and Evaluation of Acyclovir Orodispersible Tablets Using Sublimation Method. J Gen Pract 3: 208. 19. Bandameedi R, Pandiyan S (2016) Formulation and Evaluation of Floating Osmotic Tablets of Nizatidine. J App Pharm 8: 209. 20. Donthi MR, Dudhipala NR, Komalla DR, Suram D, Banala N, et al. (2015) Preparation and Evaluation of Fixed Combination of Ketoprofen Enteric Coated and Famotidine Floating Mini Tablets by Single Unit Encapsulation System. J Bioequiv Availab 7: 279-283. 21. Donthi MR, Dudipala N, Komalla DR, Suram D, Thallapally V, et al. (2015) Design and Evaluation of Floating Multi Unit Mini Tablets (MUMTS) Muco Adhesive Drug Delivery System of Famotidine to Treat Upper Gastro Intestinal Ulcers. J Pharmacovigil 3: 179.

References

22. Belafkih B, Belouafa S, Bennamara A, Skalli A and Abourriche A, et al. (2015) LC-MS/MS Analysis of MDMA in Ecstasy Tablets in Morocco. J Forensic Res 6: 301.

1. Kogawa AC, Salgadoa HRN (2016) Optimization of Microbiological Method by Turbidimetry for Quantification of Rifaximin Tablets: Validation, Application and Evaluation of Degraded Compounds. Pharm Anal Acta 7: 518.

23. Vargas M, Bustamante C and Villarraga Ea (2015) Bioequivalence Study of Two Formulations Containing Rosuvastatin 40 Mg Tablets in Healthy Colombians. J Bioequiv Availab 7: 229-232.

2. Vargas M, Villarraga EA (2016) Bioequivalence Study of Two Formulations Containing Bosutinib 500 mg Tablets in Healthy Colombian Volunteers. J Bioequiv Availab 9: 299-301.

24. Bustami R, Khasawneh S, Absi W, Feddah H, Mroueh M, et al. (2015) Bioequivalence of Losartan/Amlodipine Fixed Dose Combination Tablets (Losanet AM) Compared with Concomitant Administration of Single Components of Losartan and Amlodipine Tablets in Healthy Human Volunteers. J Bioequiv Availab.

3. Sravya I (2016) Tablets Manufacturing Methods and Granulation Techniques. Research & Reviews: Journal of Pharmacology and Toxicological Studies. 4. Harita B (2015) A Short Review on Mouth Dissolving Tablets. Journal of Pharmacy and Pharmaceutical Sciences. 5. Varma K (2016) Excipients used in the Formulation of Tablets. Journal of Chemistry. 6. Bustami R, Khasawneh S, Absi W, Feddah H, Menassa M, et al. (2016) Bioequivalence of a Fixed Dose Combination of Desloratadine/Betamethasone Tablets (Oradus Beta) in Healthy Human Volunteers. J Bioequiv Availab. 7. Anusha JSK, Karthik M (2016) A Review on Bilayered Tablets. Journal of Pharmacy and Pharmaceutical Sciences.

J Formul Sci Bioavailab, an open access journal

25. Vargas M, Bustamante C, Villarraga EA (2015) Fed and Fasting Bioequivalence Study for Two Formulations of Bosentan 125 Mg Tablets in Healthy Colombian People. J Bioequiv Availab 7: 229-232. 26. Muñoz E, Ocampo D, Yepes N (2015) Bioequivalence Study of Two Formulations of Escitalopram Oxalate 20 mg Tablets in Healthy Volunteers. J Bioequiv Availab 7: 205-209. 27. Vargas M, Bustamante C, Villarraga EA (2015) Bioequivalence Study of Two Formulations Containing Irbesartan 300 Mg Tablets in Healthy Colombian Volunteers. J Bioequiv Availab 7: 205-209. 28. Liebowitz MR, Salmán E, Johnso A, Hanover R (2015) A 12-Week Double-

Volume 1 • Issue 1 • 1000107

Citation: Haritha B (2017) A Review on Evaluation of Tablets. J Formul Sci Bioavailab 1: 107.

Page 4 of 5 Blind, Placebo-Controlled, Flexible-Dose Trial of Desvenlafaxine ExtendedRelease Tablets in Generalized Social Anxiety Disorder. J Depress Anxiety7: 205-209. 29. Sindhu.P (2014) Formulation Development and Evaluation of Bi-Layer Sustained Release Tablets of Amlodipine and Metaprolol. Journal of Pharmacy and Pharmaceutical Sciences. 30. Nagashree K (2015) Solid dosage forms: Tablets. Pharmaceutical analysis. 31. Sasidhar R (2015) Characterisation of Sustained Release Bilayer Tablets of Pioglitazone and Metformin. Pharmaceutical analysis. 32. Sasidhar R (2015) Evaluation of Oral Mucoadhesive Metoprolol succinate Controlled Release Tablets. Research & Reviews: Journal of Pharmaceutical analysis. 33. Sasidhar R (2015) Floating Tablets of Glipizide using Eurayle Ferox seeds for the treatement of Diabetis Mellitus. Pharmaceutical analysis. 34. Sowjanya P, Sathyaraj A (2015) Formulation and development of Mucoadhesive tablets of Lamivudine by direct compression technique. Journal of Pharmaceutics and Nanotechnology. 35. Hadad GM, Abdel Salam RA and Elkhoudarya MM (2015) Simultaneous Determination of Clarithromycin, Tinidazole and Omeprazole in Helicure Tablets Using Reflectance Near-Infrared Spectroscopy with the Aid of Chemometry. Pharm Anal Acta 6: 354. 36. SallamA, Isam I, Salem, Dalia Al, Johari, et al. (2015) Bioequivalence of Two Oral Formulations of Modafinil Tablets in Healthy Male Subjects under Fed and Fasting Conditions. J Bioequiv Availab. 37. Agatonovic-Kustrin S, Morton DW, Singh R, Baboota S, Talegaonkar S, et al. (2015) Biorelevant Dissolution Studies of Pioglitazone Hcl Immediate Release Tablets and the Determination of an In Vitro In Vivo Correlation. J Bioequiv Availab.

Formulation and Evaluation of Floating Nateglinide Tablets Using Factorial Design. Pharmaceutical Analysis. 50. Rani TS, Sujatha K, Chitra K, Jacob DM, Yandapalli R, et al. (2012) Spectrophotometric Method for Estimation of Tenofovir Disoproxil Fumarate in Tablets. Pharmaceutical Analysis. 51. Kumari PK, Sankar G, Sowjanya P, Madhubabu S (2014) Stability Indicating RP-HPLC method Development and Validation of Salicylic Acid in Choline Magnesium Trisalicilate (Trilisate) Tablets. J Pharma Care Health Sys 1: 4. 52. Devineni D, Curtin CR, Ariyawansa J, Weiner S, Stieltjes H, et al. (2014) Bioequivalence of Canagliflozin/Metformin Immediate Release Fixed- Dose Combination Tablets Compared with Concomitant Administration of Single Components of Canagliflozin and Metformin in Healthy Fed Participants. J Bioequiv Availab 6: 164-173. 53. Zhang X, Zhang S (2014) Bioequivalence Study of Two 30 Mg Tolvaptan Tablets Formulations in Healthy Chinese under Fed Condition. J Bioequiv Availab 6: 181-185. 54. Shedage A, Khanna A, Gole M, Purandare S, Malhotra G, et al. (2014) Comparative Steady State Cross-Over Bioequivalence Study of 35mg Trimetazidine Extended-Release Tablets. J Bioequiv Availab. 55. Malhotra B, Matschke K, Bramson C, Wang Q, Salageanu, et al. (2014) Relative Bioavailability Study of an Abuse-Deterrent Formulation of Extended-Release Oxycodone with Sequestered Naltrexone (ALO-02) Versus Immediate-Release Oxycodone Tablets in Healthy Volunteers. J Bioequiv Availab. 56. Damodar R, Movva B, Mallikarjun PN, Pasumarthy C, Kona N, et al. (2014) Formulation and Evaluation of Fast Dissolving Tablets of Diclofenac Sodium by Novel Hole Technology. J Mol Pharm Org Process Res 2: 116. 57. Osaka I, Ono S, Aikawa A, Kimura A, Shizusawa Y, et al. (2014) Prophylactic Use of Fentanyl Buccal Tablets for Predictable Breakthrough Pain: A Case Report. J Palliat Care Med 4: 191.

38. Prasanth VV, Lohumi A, Tribedi S, Mathappan R, Mathew ST, et al. (2013) Formulation and Evaluation of Gastro Retentive Floating Tablets of Stavudine. Journal of Pharmacy and Pharmaceutical Sciences

58. Muhammad IN, Shoaib MH, Yousuf RI (2014) Pharmacokinetic and Bioequivalence Studies of Oral Cefuroxime Axetil 250 mg Tablets in Healthy Human Subjects. J Bioequiv Availab 6: 149-152.

39. Prasanth VV, Sarkar S, Tribedi S, Mathappan R, Mathew ST, et al. (2013) Formulation and Evaluation of Orodispersible Tablets of Salbutamol Sulphate. Journal of Pharmacy and Pharmaceutical Sciences.

59. Jawhari D, Alswisi M, Ghannam M Halman JA, et al. (2014) Bioequivalence of a New Generic Formulation of Erlotinib Hydrochloride 150 mg Tablets versus Tarceva in Healthy Volunteers under Fasting Conditions. J Bioequiv Availab 6: 119-123.

40. Kishore SV, Tejeswara BR, Kumar YS, Nagasen D (2013) Design of Orodispersible Tablets of Losartan Potassium Using Novel Co-Processed Superdisintegrants. Journal of Pharmacy and Pharmaceutical Sciences. 41. Surinder K, Tusharkumar SH, Ezhilmuthu RP, Senthilkumar KL (2013) Taste Masking of Sitagliptin Phosphate Monohydrate By Ion Exchange Resin and Formulation of Rapidly-Disintegrating Tablets. Journal of Pharmacy and Pharmaceutical Sciences. 42. Kishor D, Gowtham VK, Sudheer B, Sandeep M (2013) Design and Development of Fast Dissolving Tablets of Ibuprofen. Journal of Pharmacy and Pharmaceutical Sciences. 43. Anand C, Vidyasagar G, Rajmane M (2013) Approach of Solid Dispersion and Polymer Coating in Formulation of Rapid Dispersible Tablets of Paracetamol. Journal of Pharmacy and Pharmaceutical Sciences. 44. Anand C, Vidyasagar G, Rajmane M (2013) Formulation and Evaluation of Matrix Tablets of Albendazole for Colon Site Specific Drug Delivery. Journal of Pharmacy and Pharmaceutical Sciences. 45. Abhilash G, Baby B, Prakash B, Rajan SR, Ramesh K, Ravi GK et al. (2013) Comparative Study on the Efficiency of Various Binder Combinations for Metformin Tablets. Journal of Pharmacy and Pharmaceutical Sciences. 46. Pavan M, Prasanth VV, Sharma A, Chauhan A, Mathappan R, et al. (2014) Formulation and Evaluation of Dicloxacillin Sodium Floating Tablets. Pharmacy and pharmaceutical sciences. 47. Suthar RM, Chotai NP, Digesh DS, Thumar RM, Patel HK, et al. (2012) Development of Fast Dissolving Tablets Containing Ondansetron via Camphor Sublimation and its Characterization. Journal of Pharmacy and Pharmaceutical Sciences. 48. Prakash KV, Pulla RP, Kumar YK (2014) Development and Validation of Rasagiline Tartrate in Tablets by using Liquid Chromatography. Pharmaceutical Analysis. 49. Prakash Om, Saraf S, Rahman M, Agnihotri N, Vinay Pathak (2013)

J Formul Sci Bioavailab, an open access journal

60. Damodar R, Movva B (2014) Preparation and In-vitro Evaluation of Metformin HCl Tablets Containing Sustained Release Beads for Increasing Therapeutic Window. J Bioequiv. 61. Muñoz E, Horacio D, Espinal E and Yépes N (2014) Bioequivalence Study of Two 10 mg Montelukast Immediate-Release Tablets Formulations: A Randomized, Single-Dose, Open-Label, Two Periods, Crossover Study. J Bioequiv Availab. 62. Chik Z, Deril NM, Didi EMH, Basu RC, Ratnasingam J, et al. (2014) A Bioequivalence Comparison of Two Captopril Formulations (25 mg Tablets): An Open-Label, Randomized, Two-Treatment, Two-Way Crossover Study in Healthy Volunteers. J Bioequiv Availab. 63. Kutzleb J, Elmann N, Fruhschien A, Angeli S, Mulkay A (2014) The Use of 4G Android Tablets for Enhanced Patient Activation of Chronic Disease SelfManagement in People with Heart Failure. J Nurs Care. 64. Salem H, Riad SM, Rezk MR, Ahmed K (2014) Simultaneous Determination of Omeprazole, Tinidazole and Clarithromycin in Bulk Powder and Helicure Tablets by HPLC. J Chromat Separation Techniq. 65. Friedrich C, Brand T, Ring A (2014) Bioequivalence of Glucophage® (Metformin) Tablets from Europe and the United States Tested in Healthy Volunteers. J Bioequiv Availab. 66. Renati D, Vinay CV (2014) Role of Novel Hole Technology in Fast Dissolving Tablets. J Mol Pharm Org Process Res. 67. (2010) Determination of 3,4-methylenedioxymethamphetamine (MDMA) in Confiscated Tablets by High-Performance Liquid Chromatography (HPLC) with Diode Array Detector. J Forensic Res 2010, 1: 106 DOI: 10.4172/21577145.1000106 68. Kassem MA, El-Sayed GO (2014) Adsorption of Tartrazine on Medical Activated Charcoal Tablets under Controlled Conditions. J Environ Anal Chem. 69. Usman S, Alam A, Nadeem N (2014) Biowaiver Studies of Atenolol Tablets

Volume 1 • Issue 1 • 1000107

Citation: Haritha B (2017) A Review on Evaluation of Tablets. J Formul Sci Bioavailab 1: 107.

Page 5 of 5 (100mg) - An Alternative to In Vivo Bioequivalence Studies. Nat Prod Chem Res. 70. Menkovska M (2013) The Newest Experience with Effervescent Tablets Containing Royal Jelly as Functional Food on Packing, Dosage and Synergistic Action in Prevention, Prophylaxis and Healing. J Food Process Technol. 71.

Lories IB, Mostafa AA, Girges MA (2013) High Performance Liquid Chromatography, TLC Densitometry, Firstderivative and First-derivative ratio spectrophotometry for de-termination of Rivaroxaban and its alkaline Degradates in Bulk Powder and its Tablets. J Chromat Separation Techniq.

72. Watson CJ, Souza D, Silva C (2013) Attempt to Detect Garlic Allyl Sulphides from Saliva after Consumption of Garlic Tablets Using GC-MS. J Microbial Biochem Technol. 73. Hu L, Gu D (2013) A Novel Approach to Formulate and Optimize Orally Disintegrating Tablets of Bambuterol Hydrochloride. Pharmaceut Anal Acta. 74. Menon S, Kandari K, Mhatre M (2013) Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of Armodafinil 250 mg Tablets in Healthy Indian Adult Male Subjects. J Bioequiv Availab. 75. Kaale E, Nyamweru BC, Manyanga V, (2013) The Development and Validation of a Thin Layer Chromatography Densitometry Method for the Analysis of Diclofenac Sodium Tablets. Pharmaceut Anal Acta. 76. Bhoya PN, Patelia Em (2013) Development and Validation of TLCDensitometry Method for Simultaneous Estimation of Bisoprolol Fumarate and Hydrochlorothiazide in Bulk and Tablets. J Chromat Separation Techniq. 77. Salem H, Safaa M (2012) Simultaneous Determination of Metronidazole and Diiodohydroxyquine in Bulk Powder and Paramibe Compound Tablets by TLCDensitometry and HPLC. Pharm Anal Acta. 78. Lokesh PNV, Althaf S (2012) Design, Development and Formulation of Orodispersible Tablets of a Model Drug Using Response Surface Methodology. Pharm Anal Acta. 79. Althaf S, Sailaja PB (2012) Formulation, Evaluation and Mathematical Modelling of Clopidogrel Bisulphate & Aspirin Immediate Release Bilayer Tablets. Pharm Anal Acta. 80. Raja M, Geetha G, Sangaranarayanan A (2012) Simultaneous, Stability Indicating Method Development and Validation for Related Compounds of Ibuprofen and Paracetamol Tablets by RP-HPLC Method. J Chromat Separation Techniq. 81. Ansary A, Abdel-Moety MM, Abdel-Gawad FM, Mohamed EA, Khater MM, et al. (2012) Simultaneous Determination of Carvedilol and Hydrochlorothiazide in Tablets and Spiked Human Plasma using Derivative Spectrophotometry. Pharm Anal Acta 3: 186. 82. Ahir KB, Patelia EM, Mehta FA (2012) Simultaneous Estimation of Nebivolol Hydrochloride and Hydrochlorothiazide in Tablets by TLC-Densitometry. J Chromat Separation Techniq 3: 141. 83. El-Din MS, Eid M, Zeid AM (2012) Development and Validation of RP- HPLC Method for Simultaneous Determination of Ascorbic Acid and Salicylamide in their Binary Mixtures: Application to Combined Tablets. J Chromat Separation Techniq 3: 137. 84. Ratnaparkhi MP (2012) Formulation and Development of Taste Masked Orally Disintegrating Tablets of Perindopril Erbumine by Direct Compression Method. Pharm Anal Acta 3: 162.

88. Usman M, Ali I, Bibi H, Iqbal J, Iqbal K, et al. (2012) Preparation and Evaluation of Controlled Release Tablets Containing Mefenamic Acid. Clin Exp Pharmacol 2: 107. 89. Usman M, Ali I, Bibi H, Iqbal J, Iqbal K, et al. (2012) Bioequivalence Evaluation of Two Formulations of Lamotrigine Tablets in Healthy Volunteers. JBB 4: 030-034. 90. Usman M, Ali I, Bibi H, Iqbal J, Iqbal K, et al. (2012) Bioequivalence Study of Two Oral Formulations of Memantine Tablets in Healthy Brazilian Volunteers after a Single Dose Administration. JBB 4: 014-017. 91. Jian-Jun Z, Tan J, Hong-Wei F, Shao-Liang C (2012) Bioequivalence Study of Clopidogrel 75 Mg Tablets in Healthy Male Volunteers. JBB 4: 006-009. 92. Alonso-Campero R, Bernardo-Escudero R, Francisco-Doce MTJ, CortésFuentes M, Gilberto Castañeda-Hernandez G, et al. (2011) Bioequivalence Study of Metoclopramide Hydrochloride 10 mg Tablets in Healthy Male Volunteers. JBB 3: 222-227. 93. Alonso-Campero R, Bernardo-Escudero R, Francisco-Doce MTJ, CortésFuentes M, Gilberto Castañeda-Hernandez G, et al. (2011) Bioequivalence Study of Norfloxacin Tablets (Oranor® and Noroxin®) in Healthy Male Volunteers. A Single Dose, Randomized, Open-label, 2 x 2 Cross-over, in Fasting Conditions Study. JBB 3: 215-221. 94. Bragatto MS, dos Santos MB, Pinto AMP, Gomes E, Angonese NT, et al. (2011) Comparison between Pharmacokinetic and Pharmacodynamic of Single- Doses of Furosemide 40 mg Tablets. JBB 3: 191-197. 95. Frag EYZ, Mohamed GG, Alelaiwi HMS (2011) Utility of Ion-associate Formation Reactions for the Spectrophotometric Determination of Sildenafil Citrate in Pure form and in Virecta Tablets. Pharm Anal Acta 2: 131. 96. Jawhari D, AlSwisi M (2011) Bioavailability of a New Generic Formulation of Imatinib Mesylate 400mg Tablets Versus Glivec in Healthy Male Adult Volunteers. JBB 3: 161-164. 97. Somagoni JM, Reddy S, Koorelli S, Manda S, Yamsani MR, et al. (2011) Enantiomeric Separation and Determination of Stereospecific Drug Release from Marketed Racemic Amlodipine Besylate Tablets by HPLC. Pharm Anal Acta 2: 129. 98. Chatsiricharoenkul S, Niyomnaitham S, Pongnarin P, Sathirakul K, Kongpatanakul S (2011) Bioequivalence Study of 10 mg Olanzapine Tablets in Healthy Thai Volunteers. JBB 3: 082-085. 99. Reddy YR, Kumar KK, Reddy MRP, Mukkanti K (2011) Rapid Simultaneous Determination of Sumatriptan Succinate and Naproxen Sodium in Combined Tablets by Validated Ultra Performance Liquid Chromatographic Method. J Anal Bioanal Techniques 2: 121. 100. Bari SB, Bakshi AR, Jain PS, Surana SJ (2011) Application of UVSpectroscopy and First Order Derivative Method for Determination of Tamsulosin Hydrochloride in Bulk and Tablets. Pharm Anal Acta 2: 120. 101. Caro VD, Giandalia G, Siragusa MG, Campisi G, Giannola LI (2009) Galantamine Delivery on Buccal Mucosa: Permeation Enhancement and Design of Matrix Tablets. JBB 1: 127-134. 102. Khattak S, Malik F, Hameed A, Ahmad S, Rizwan M, et al. (2010) Comparative Bioavailability Assessment of Newly Developed Flurbiprofen Matrix Tablets and Froben SR® Tablets in Healthy Pakistani Volunteers. JBB 2: 139-144.

85. Jagadeeswaran M, Gopal N, Kumar KP, Kumar TS (2012) Quantitative Estimation of Lopinavir and Ritonavir in Tablets by RP-HPLC Method. Pharm Anal Acta 3: 160. 86. Nanjwade BK, Adichwal SA, Nanjwade VK, Gaikwad KR, Thakare SA, et al. (2012) Development and Evaluation of Gastroretentive Floating Tablets of Glipizide Based on Effervescent Technology. J Drug Metab Toxicol. 87. Qiu X, Xiang R, Dai Q, Yang B, Xiong L, et al. (2012) Pharmacokinetics and Bioequivalence Evaluation of Two Voriconazole tablets: An Open-Label, Single-Dose, Randomized, Two-Way Crossover Study in Healthy Chinese Male Volunteers. JBB 4: 044-047.

J Formul Sci Bioavailab, an open access journal

Volume 1 • Issue 1 • 1000107